Lelaiwa Consulting Service Center
You are here: Home > News > IVF Information
The genetic code of IVF abortion: How genetic testing solves the fertility dilemma
Source: LelaiwaPublished: 2025-07-23
This article is compiled and published by the lelaiwa team. Unauthorized reproduction is prohibited. For ongoing updates on fertility preparation, IVF, and overseas or U.S. childbirth, scan the consultant's QR code on the right to get free updates, or contact lelaiwa for free consultation anytime.

1. Embryo chromosomal abnormalities: the primary "genetic culprit" of abortion
1. Core factors accounting for more than 50%
Clinical data shows that 50%-70% of early abortions of IVF are directly related to chromosomal abnormalities in the embryo. Exception types include:
③ Abnormal numbers: For example, trisomy (one more) or monomers (one less) on chromosomes 16 and 21, accounting for more than 80% of abnormal embryos. Elderly women (35 years old) have a 50% risk of embryo aneuploidy due to egg meiosis errors.
③ Structural abnormalities: Chromosomal translocations, inversions or deletions are common when one spouse is a carrier of balanced translocation, and the probability of normal embryo development is less than 20%.
2. Sources of abnormalities: parental inheritance and fertilization mutations
④ Genetic transmission: Parents carry chromosomal structural abnormalities or monogenic diseases (such as thalassemia), and the embryo has a 25% chance of developing the disease.
④ New mutations: Chromosome copying errors during fertilization (such as polyspermia), environmental toxins (formaldehyde/radiation) or aging of elderly eggs can lead to spontaneous mutations.

2. Genetic testing technology: from passive elimination to active prevention and control
1. Precise interception of third-generation test tube (PGT)
④ PGT-A (aneuploidy screening): Scan 23 pairs of chromosomes in the blastocyst to eliminate trisomy/single embryos, reducing the risk of abortion by more than 50%. For example, after a 38-year-old patient is screened for PGT-A
④ PGT-M (Monogenic Disease Blocking): Targeting genetic diseases such as hemophilia and spinal muscular atrophy
2. Technical limitations and breakthroughs
④ The problem of misdiagnosis of chimeras: About 15% of embryos have normal cells and abnormal cells, and traditional biopsies may miss diagnosis. The new AI dynamic imaging technology can track cell division in real time, increasing the accuracy to 95%.
▲ Blind spots for new mutations: 3% of miscarriages are caused by spontaneous genetic mutations during embryonic development, which needs to be combined with parental all-exon sequencing and traceability analysis.

3. Interaction between non-genetic factors
Although genetics is the main reason, multi-dimensional collaborative management is crucial:

factors

mechanism of action

intervention strategies

uterine microenvironment

The endometrial membrane is<7mm or the presence of polyps/adhesions increases the embryo implantation failure rate by 3 times

Hysteroscopic surgical repair+ evaluation of endometrial receptivity

endocrine disorders

Hypothyroidism (TSH 2.5mIU/L) or insufficient corpus luteum, resulting in delayed development of the endometrium

Precise supplementationof Uthyrox/progesterone

immune rejection

Anti-phospholipid antibodies attack embryonic blood vessels, triggering blood clots and blocking nutrient supply

Heparin+ aspirin anticoagulation


4. Clinical practice: Technology rewrites fertility outcomes
Case 1: Counterattack of Balanced Translocation Families
Background: The husband and wife had balanced chromosome translocation t(11;22) and had 4 spontaneous abortions.
Plan: PGT-SR technology screens embryos with normal structure.
Case 2: Breaking the situation of repeated miscarriages at an advanced age
Background: A 42-year-old woman had fetal arrest after three transplants, and the couple had normal karyotypes.
Genetic testing: PGT-A showed that 80% of embryos had aneuploidy (mainly trisomy 16).
Outcome: Successful delivery after transfer of euploid embryos.

Decoding the genetic code and reshaping fertility hope
Genetic testing technology is transforming IVF abortion from a "probability dilemma" into a preventable and controllable precision medical topic. With breakthroughs in epigenetics (such as the association between DNA methylation and abortion) and embryonic metabolomics, it is expected to achieve earlier prediction of embryonic potential in the future. At present, three generations of test-tube PGT technology combined with multi-dimensional management have become an excellent way to solve repeated abortion-allowing the seeds of life to take root and grow under the protection of science.


For more on fertility preparation, second/third-generation IVF, and overseas, U.S., Thailand, Malaysia, America or Cambodia IVF, scan the QR code on the right or call lelaiwa's hotline+852 6145 8043!
online consultation
ONLINE CONSULTATION
LINE QR code
Email an advisor